AES
39
-4
XEL
67
2
AXP
66
2
COF
55
-3
AVGO
20
-5
MRO
55
3
USB
50
2
TRV
53
-3
PDCO
35
-3
STI
47
-12
PNW
66
3
TEL
60
2
DTE
50
3
A
36
2
EQIX
60
-2
MS
74
-2
PSA
51
-4
ADP
64
2
IP
70
2
GIS
26
3
AES
39
-4
XEL
67
2
AXP
66
2
COF
55
-3
AVGO
20
-5
MRO
55
3
USB
50
2
TRV
53
-3
PDCO
35
-3
STI
47
-12
PNW
66
3
TEL
60
2
DTE
50
3
A
36
2
EQIX
60
-2
MS
74
-2
PSA
51
-4
ADP
64
2
IP
70
2
GIS
26
3
Financhill
Back

BioCardia Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
23

BCDA
BioCardia

Last Price:
2.15
Seasonality Move:
9.98%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
246.88
Seasonality Move:
10.85%
Sell
23
BioCardia (BCDA) is a Sell

Is BioCardia a Buy, Sell or Hold?

  • The current BioCardia [BCDA] share price is $2.14. The Score for BCDA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • BCDA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $246.80. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCDA Stock Price Chart

What is BioCardia's stock price today?

  • The BioCardia share price today is $2.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $246.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

BCDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 43.44 Sell
Chaikin Money Flow: 30165 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.13 - 2.55) Sell
Bollinger Bands (100): (2.35 - 3.09) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.62 Sell
Relative Strength Index (14 RSI): 38.74 Sell
Chaikin Money Flow: -304936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (252.02 - 290.24) Sell
Bollinger Bands (100): (248.77 - 281.71) Sell

BCDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.11 Buy
20-day SMA: 2.28 Sell
50-day SMA: 2.54 Sell
200-day SMA: 4.12 Sell
8-day EMA: 2.11 Buy
20-day EMA: 2.25 Sell
50-day EMA: 2.49 Sell
200-day EMA: 4.86 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 248.63 Sell
20-day SMA: 265.26 Sell
50-day SMA: 272.83 Sell
200-day SMA: 211.25 Buy
8-day EMA: 249.36 Sell
20-day EMA: 260.88 Sell
50-day EMA: 266.13 Sell
200-day EMA: 230.89 Buy

BioCardia Earnings Growth & BCDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.38 per share, and an increase next year of $2.30 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

BioCardia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):